share_log

Breaking Down Bicycle Therapeutics: 8 Analysts Share Their Views

Benzinga ·  Dec 16 13:00

In the last three months, 8 analysts have published ratings on Bicycle Therapeutics (NASDAQ:BCYC), offering a diverse range of perspectives from bullish to bearish.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings51200
Last 30D10000
1M Ago00100
2M Ago41100
3M Ago00000

The 12-month price targets, analyzed by analysts, offer insights with an average target of $37.0, a high estimate of $55.00, and a low estimate of $17.00. Observing a downward trend, the current average is 14.81% lower than the prior average price target of $43.43.

bigjpg

Interpreting Analyst Ratings: A Closer Look

The perception of Bicycle Therapeutics...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment